|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence显示文摘BACKGROUND Patients with an in-breast tumor recurrence(IBTR)after breast-conserving therapy have a high risk of distant metastasis and disease-related mortality.Classifying clinical parameters that increase risk for recurrence after IBTR remains a challenge.AIM To describe primary and recurrent tumor characteristics in patients who experience an IBTR and understand the relationship between these characteristics and disease outcomes.METHODS Patients with stage 0-II breast cancer treated with lumpectomy and adjuvant radiation were identified from institutional databases of patients treated from 2003-2017 at our institution.Overall survival(OS),disease-free survival,and local recurrence-free survival(LRFS)were estimated using the Kaplan Meier method.We identified patients who experienced an isolated IBTR.Concordance of hormone receptor status and location of tumor from primary to recurrence was evaluated.The effect of clinical and treatment parameters on disease outcomes was also evaluated.RESULTS We identified 2164 patients who met the eligibility criteria.The median follow-up for all patients was 3.73[interquartile range(IQR)2.27-6.07]years.Five-year OS was 97.7%(95%CI:96.8%-98.6%)with 28 deaths;5-year LRFS was 98.0%(97.2-98.8)with 31 IBTRs.We identified 37 patients with isolated IBTR,19(51.4%)as ductal carcinoma in situ and 18(48.6%)as invasive disease,of whom 83.3%had an in situ component.Median time from initial diagnosis to IBTR was 1.97(IQR:1.03-3.5)years.Radiotherapy information was available for 30 of 37 patients.Median whole-breast dose was 40.5 Gy and 23 patients received a boost to the tumor bed.Twenty-five of thirty-two(78.1%)patients had concordant hormone receptor status,HER-2 receptor status,and estrogen receptor(ER)(P=0.006)and progesterone receptor(PR)(P=0.001)status from primary to IBTR were significantly associated.There were no observed changes in HER-2 status from primary to IBTR.The concordance between quadrant of primary to IBTR was 10/19[(62.2%),P=0.008].Tumor size greater than 1.5 cm(HR=0.44,95%CI:0.22-0.90,P=0.02)and use of endocrine therapy upfront(HR=0.36,95%CI:0.18-0.73,P=0.004)decreased the risk of IBTR.CONCLUSION Among patients with early stage breast cancer who had breast conserving surgery treated with adjuvant RT,ER/PR status and quadrant were highly concordant from primary to IBTR.Tumor size greater than 1.5 cm and use of adjuvant endocrine therapy were significantly associated with decreased risk of IBTR. | Juhi M Purswani Fauzia Shaikh S Peter Wu Jennifer Chun Kim Freya Schnabel Nelly Huppert Carmen A Perez Naamit K Gerber | 2020 | World Journal of Clinical Oncology2020，11，1： | 2 |
| 2 | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer 显示文摘 | Ferrara N Hillan K J Gerber HP | 2004 | Nat Rev Drug Discov2004，3，5： | 1 |
| 3 | A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2,PRRSV and PPV infection显示文摘 | Opriessnig T ONeill K Gerber P F | 2013 | Vaccine2013，31，3： | 1 |
| 4 | VEGF regulateshaematopoietic stem cell survival by an internal autocrine loopmechanism显示文摘 | Gerber H P Malik A K Solar G P | 2002 | Nature2002，417，6892： | 1 |
| 5 | Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone显示文摘 | GERBER J POHL K SANDER V | 2003 | Antimicrob Agents Chemother2003，47，4： | 1 |
| 6 | Capillary regression in vascular endothelial growth factor-deficient skeletal muscle显示文摘 | Tang K Breen E C Gerber H P | | 0，，01： | 1 |
| 7 | Targeting VEGF ligands and receptors in cancer显示文摘 | Malik A K Gerber H | 2003 | Targets2003，2，2： | 1 |
| 8 | Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway 显示文摘 | Menge T Gerber M Wataha K | 2013 | Stem Cells Dev2013，22，1： | 1 |
| 9 | Discovery and outcome of bevacizumab,an anti-VEGF antibody for treating cancer显示文摘 | Hillan K Gerber H | 2004 | Nat Rev Drug Discov2004，3，5： | 1 |
| 10 | Cancer-related fatigue: Implications for breast cancer survivors显示文摘 | Berger A M Gerber L H Mayer D K | 2012 | Cancer2012，118，8： | 1 |
| 11 | A PCV2 vaccine based on genotype 2b is more effective than a 2a based vaccine to protect against PCV2b or corn-bined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection显示文摘 | Opriessnig T O~Neill K Gerber P F | 2013 | Vaccine2013，31，3： | 1 |
| 12 | Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer显示文摘 | Ferrara N Hillan K J Gerber HP Novotny W | 2004 | Nat Rev Drug Discov2004，3，5： | 1 |
| 13 | VEGF is required for growth and survival in neonatal mice显示文摘 | Gerber H P Hillan K J Ryan A M | 1999 | Development1999，126，6： | 1 |
| 14 | Joining the cell survival squad : an emerging role for protein kinase CK2 显示文摘 | Hmed K Gerber DA Cochet C | 2002 | Trends Cell Biol2002，12，5： | 1 |
| 15 | Biomedical nanoparticles modulate specific CD4 + T cell stimulation by inhibition of antigen processnig in dendritic cells显示文摘 | Blank F Gerber P Rothen-Rutishauser B Sakulkhu U Salaklang J De Peyer K | | 0，，： | 1 |
| 16 | Drosophila ELL is associated with actively elongating RNA polymerase Ⅱ on transcriptionally active sites in vivo显示文摘 | Gerber M J Ma K Dean J C | 2001 | Embo J2001，20，21： | 1 |
| 17 | Computational discovery of gene modules and regulatory networks显示文摘 | BAR-JOSEPH Z GERBER G K LEE T I | 2003 | Nature Biotechnology2003，21，11： | 1 |
| 18 | VEGF is required for growth and survival in neonatal mice显示文摘 | GERBER H P HILLAN K J RYAN A M | 1999 | Development1999，126，6： | 1 |
| 19 | VEGF is required for growth and survival in neonatal mice显示文摘 | Gerber HP Hillan K J Ryan AM | 1999 | Development1999，126，6： | 1 |
| 20 | VEGF regulates haematopoieric stem cell survival by an irttemal ttutocrine loop mechanism显示文摘 | Gerber H P Malik A K Solar G P | 2002 | Nature2002，417，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员